Search results
Pfizer expands cost cuts with new $1.5B target
BioPharma Dive via Yahoo Finance· 3 days agoThe company, which previously announced plans to trim $4 billion in spending by the end of 2024, aims to save another $1.5 billion over the next three...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 3 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 3 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 5 days agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 2 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
Endpoints News· 2 days agoWhen Pfizer laid out the ambitious vision for its new oncology division in February, it announced...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 3 days agoPfizer is launching a multi-year cost reduction program expected to include operational efficiencies, network structure changes, and product portfolio...
Pfizer's $1.5B cuts; Biogen's $1.15B buyout; AstraZeneca's $80B ambition; RNA startup merger; and...
Endpoints News· 17 hours agoWant this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. Whether you will be in San Diego for BIO, we hope you will join ...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 3 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...